Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate HighlightsGlobeNewsWire • 11/06/24
Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024GlobeNewsWire • 10/30/24
Strength Seen in Relay Therapeutics (RLAY): Can Its 6.7% Jump Turn into More Strength?Zacks Investment Research • 09/17/24
Relay Therapeutics' RLY-2608 Shows Promise For Breast Cancer With PI3Kα MutationsSeeking Alpha • 09/11/24
GameStop Reports Weak Sales, Joins Petco, Relay Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionBenzinga • 09/11/24
Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor MarketBenzinga • 09/10/24
This Johnson Controls International Analyst Turns Bullish; Here Are Top 5 Upgrades For TuesdayBenzinga • 09/10/24
Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated PatientsBenzinga • 09/09/24
Relay Therapeutics' combo therapy for breast cancer cuts disease progression in early studyReuters • 09/09/24
Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free SurvivalGlobeNewsWire • 09/09/24
Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024GlobeNewsWire • 09/06/24
Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate HighlightsGlobeNewsWire • 08/06/24
Relay Therapeutics Discloses Three New Programs at New Program & Platform EventGlobeNewsWire • 06/06/24
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608GlobeNewsWire • 06/05/24
Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/02/24
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate HighlightsGlobeNewsWire • 05/02/24
Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024GlobeNewsWire • 04/25/24